In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

BHUBANESWAR: In a major push to accelerate bio-industrialisation, the state government has announced a comprehensive ...

As of Friday, January 09, Zhengye Biotechnology Holding Limited’s ZYBT share price has surged by 5.27%, which has investors ...

Gandhinagar: A recent NITI Aayog report on the globalisation of higher education has praised the Gujarat government's ...

Thinking about age as a modifiable risk factor is reshaping how veterinarians approach care for aging dogs.

One of the ones that we're particularly interested in at Loyal is something called metabolic dysfunction. As people and dogs ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity ...

Access the Akari CEO Corner hereTAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: ...

SEED Therapeutics, Inc. ("SEED"), a clinical-stage biotechnology company specializing in molecular glue degraders, today announced the dosing of the first patient in its Phase 1a dose-escalation study ...

A new type of “smart pill” designed to confirm when medications are actually swallowed could one day help doctors better ...

No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...

Vetr announced the commercial availability of ToltraMax, a toltrazuril oral solution that does not require a prescription and is intended for companion animals and non-food-chain animals. The product ...